NCT Number: NCT03068702
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)
Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.
Looking for future studies?
Notify MeKey information
About this study
this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
people with sickle cell trait or sickle cell disease -
Exclusion criteria
-
Treatment and study plan
Primary outcomes
-
vascular changes seen in the macular vasculature of people with sickle cell disease/ trait as compared to macular vasculature of normal macula.
Time frame: through study completion, an average of one year
in this angiography the delicate vasculature of the macula can be clearly visualized and documented.
Sponsors and collaborators
Lead sponsor
Dr. S.S. Michel Clinic
Other
Registry information
Official study title
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy
Acronym: OCTA
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Mar 3, 2017
- Registry last updated
- Mar 3, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy
NCT06396403
Anemia, Anemia, Hemolytic
Amsterdam, North Holland, Netherlands
View Trial Details